4.8 Article

Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 116, Issue 4, Pages 996-1004

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI26490

Keywords

-

Funding

  1. NHLBI NIH HHS [P50 HL056389, HL77430, R01 HL077430, P50 HL56389] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI048927, AI48927] Funding Source: Medline

Ask authors/readers for more resources

Studies in humans and mice show an important role for Tregs in the control of immunological disorders. The mechanisms underlying the immunosuppressive functions of Tregs are not well understood. Here, we show that CD4(+) T cells expressing Foxp3 and membrane-bound TGF-beta (TGF-beta(m+)Foxp3(+)), previously shown to be immunosuppressive in both allergic and autoimmune diseases, activate the Notch1-hairy and enhancer of split 1 (Notch1-HES1) axis in target cells. Soluble TGF-beta and cells secreting similar levels of soluble TGF-beta were unable to trigger Notch1 activation. Inhibition of Notch1 activation in vivo reversed the immunosuppressive functions of TGF-beta(m+)Foxp3(+) cells, resulting in severe allergic airway inflammation. Integration of the TGF-beta and Notch1 pathways may be an important mechanism for the maintenance of immune homeostasis in the periphery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available